annual operating expenses:
$4.70B+$249.00M(+5.59%)Summary
- As of today (September 17, 2025), TEVA annual total operating expenses is $4.70 billion, with the most recent change of +$249.00 million (+5.59%) on December 31, 2024.
- During the last 3 years, TEVA annual operating expenses has risen by +$205.00 million (+4.56%).
- TEVA annual operating expenses is now -33.33% below its all-time high of $7.05 billion, reached on December 31, 2016.
Performance
TEVA Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$1.23B+$62.06M(+5.32%)Summary
- As of today (September 17, 2025), TEVA quarterly total operating expenses is $1.23 billion, with the most recent change of +$62.06 million (+5.32%) on June 30, 2025.
- Over the past year, TEVA quarterly operating expenses has increased by +$20.06 million (+1.66%).
- TEVA quarterly operating expenses is now -48.61% below its all-time high of $2.39 billion, reached on December 31, 2013.
Performance
TEVA quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
TEVA Operating expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +5.6% | +1.7% |
3 y3 years | +4.6% | +10.2% |
5 y5 years | -2.4% | +13.1% |
TEVA Operating expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +9.7% | at high | +23.2% |
5 y | 5-year | -2.4% | +9.7% | -5.8% | +23.2% |
alltime | all time | -33.3% | >+9999.0% | -48.6% | +3273.1% |
TEVA Operating expenses History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $1.23B(+5.3%) |
Mar 2025 | - | $1.17B(-2.8%) |
Dec 2024 | $4.70B(+5.6%) | $1.20B(+3.1%) |
Sep 2024 | - | $1.16B(-3.6%) |
Jun 2024 | - | $1.21B(+7.1%) |
Mar 2024 | - | $1.13B(0.0%) |
Dec 2023 | $4.45B(+3.9%) | $1.13B(+2.8%) |
Sep 2023 | - | $1.10B(-4.6%) |
Jun 2023 | - | $1.15B(+6.9%) |
Mar 2023 | - | $1.08B(+2.7%) |
Dec 2022 | $4.28B(-4.7%) | $1.05B(+5.1%) |
Sep 2022 | - | $997.00M(-10.5%) |
Jun 2022 | - | $1.11B(+2.9%) |
Mar 2022 | - | $1.08B(-4.1%) |
Dec 2021 | $4.50B(-3.7%) | $1.13B(+4.0%) |
Sep 2021 | - | $1.09B(-1.7%) |
Jun 2021 | - | $1.10B(+0.3%) |
Mar 2021 | - | $1.10B(-15.4%) |
Dec 2020 | $4.67B(-3.1%) | $1.30B(+14.1%) |
Sep 2020 | - | $1.14B(+5.2%) |
Jun 2020 | - | $1.09B(-4.6%) |
Mar 2020 | - | $1.14B(-9.4%) |
Dec 2019 | $4.82B(-11.3%) | $1.26B(+12.1%) |
Sep 2019 | - | $1.12B(-9.5%) |
Jun 2019 | - | $1.24B(+3.1%) |
Mar 2019 | - | $1.20B(-16.4%) |
Dec 2018 | $5.43B(-18.1%) | $1.44B(+5.4%) |
Sep 2018 | - | $1.36B(+5.8%) |
Jun 2018 | - | $1.29B(-6.9%) |
Mar 2018 | - | $1.38B(+2.8%) |
Dec 2017 | $6.62B(-6.0%) | $1.35B(-22.9%) |
Sep 2017 | - | $1.75B(-1.7%) |
Jun 2017 | - | $1.78B(+1.1%) |
Mar 2017 | - | $1.76B(-17.3%) |
Dec 2016 | $7.05B(+10.8%) | $2.12B(+11.0%) |
Sep 2016 | - | $1.91B(+16.8%) |
Jun 2016 | - | $1.64B(+6.9%) |
Mar 2016 | - | $1.53B(-7.3%) |
Dec 2015 | $6.36B(-3.1%) | $1.65B(+13.5%) |
Sep 2015 | - | $1.46B(-7.3%) |
Jun 2015 | - | $1.57B(+0.6%) |
Mar 2015 | - | $1.56B(-8.4%) |
Dec 2014 | $6.57B(-2.7%) | $1.71B(+3.0%) |
Sep 2014 | - | $1.66B(+5.3%) |
Jun 2014 | - | $1.57B(-4.1%) |
Mar 2014 | - | $1.64B(-31.4%) |
Dec 2013 | $6.75B(+4.2%) | $2.39B(+43.4%) |
Sep 2013 | - | $1.67B(-4.4%) |
Jun 2013 | - | $1.74B(+3.5%) |
Mar 2013 | - | $1.68B(-7.2%) |
Dec 2012 | $6.47B(+17.6%) | $1.81B(+23.6%) |
Sep 2012 | - | $1.47B(-5.4%) |
Jun 2012 | - | $1.55B(+6.0%) |
Mar 2012 | - | $1.47B(-32.5%) |
Dec 2011 | $5.50B(+15.1%) | $2.17B(+90.8%) |
Sep 2011 | - | $1.14B(-17.7%) |
Jun 2011 | - | $1.38B(+4.7%) |
Mar 2011 | - | $1.32B(-2.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2010 | $4.78B(+11.2%) | $1.35B(+11.5%) |
Sep 2010 | - | $1.21B(+14.0%) |
Jun 2010 | - | $1.06B(-7.0%) |
Mar 2010 | - | $1.14B(-6.3%) |
Dec 2009 | $4.30B(-8.5%) | $1.22B(+14.1%) |
Sep 2009 | - | $1.07B(+6.8%) |
Jun 2009 | - | $998.48M(-3.8%) |
Mar 2009 | - | $1.04B(+15.0%) |
Dec 2008 | $4.70B(+89.3%) | $902.66M(+6.4%) |
Sep 2008 | - | $848.62M(+0.2%) |
Jun 2008 | - | $846.73M(+23.0%) |
Mar 2008 | - | $688.58M(-6.7%) |
Dec 2007 | $2.48B(+14.7%) | $738.27M(+23.5%) |
Sep 2007 | - | $597.74M(-4.6%) |
Jun 2007 | - | $626.86M(+6.2%) |
Mar 2007 | - | $590.06M(-3.6%) |
Dec 2006 | $2.16B(+85.2%) | $612.10M(+14.6%) |
Sep 2006 | - | $534.06M(+8.3%) |
Jun 2006 | - | $493.27M(+17.7%) |
Mar 2006 | - | $419.10M(+37.3%) |
Dec 2005 | $1.17B(+9.8%) | $305.27M(+1.9%) |
Sep 2005 | - | $299.57M(+9.3%) |
Jun 2005 | - | $274.09M(-1.6%) |
Mar 2005 | - | $278.41M(-2.6%) |
Dec 2004 | $1.06B(+67.8%) | $285.83M(+5.3%) |
Sep 2004 | - | $271.44M(+7.6%) |
Jun 2004 | - | $252.35M(+5.7%) |
Mar 2004 | - | $238.66M(+13.6%) |
Dec 2003 | $634.10M(+11.0%) | $210.02M(+12.5%) |
Sep 2003 | - | $186.65M(+0.7%) |
Jun 2003 | - | $185.26M(+10.8%) |
Mar 2003 | - | $167.24M(+3.1%) |
Dec 2002 | $571.40M(+21.4%) | $162.18M(+10.9%) |
Sep 2002 | - | $146.27M(+16.6%) |
Jun 2002 | - | $125.46M(-3.7%) |
Mar 2002 | - | $130.30M(+24.6%) |
Dec 2001 | $470.84M(+14.4%) | - |
Sep 2001 | - | $104.54M(-10.3%) |
Jun 2001 | - | $116.50M(-0.4%) |
Mar 2001 | - | $116.92M(-402.1%) |
Dec 2000 | $411.65M(+30.4%) | - |
Dec 1999 | $315.73M(+14.4%) | - |
Dec 1998 | $276.09M(-12.1%) | - |
Sep 1998 | - | -$38.70M(+67.9%) |
Jun 1998 | - | -$23.05M(-34.2%) |
Mar 1998 | - | -$35.06M |
Dec 1997 | $314.20M(+14.6%) | - |
Dec 1996 | $274.10M(+21.5%) | - |
Dec 1995 | $225.60M(+8.1%) | - |
Dec 1994 | $208.60M(+43.4%) | - |
Dec 1993 | $145.50M(+23.5%) | - |
Dec 1992 | $117.80M(+45.6%) | - |
Dec 1991 | $80.90M(-16.9%) | - |
Dec 1990 | $97.40M(+73.3%) | - |
Dec 1989 | $56.20M(-4.9%) | - |
Dec 1988 | $59.10M(+66.9%) | - |
Mar 1987 | $35.40M(+72.7%) | - |
Mar 1986 | $20.50M | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual total operating expenses?
- What is the all time high annual operating expenses for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual operating expenses year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly operating expenses year-on-year change?
What is Teva Pharmaceutical Industries Limited annual total operating expenses?
The current annual operating expenses of TEVA is $4.70B
What is the all time high annual operating expenses for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual total operating expenses is $7.05B
What is Teva Pharmaceutical Industries Limited annual operating expenses year-on-year change?
Over the past year, TEVA annual total operating expenses has changed by +$249.00M (+5.59%)
What is Teva Pharmaceutical Industries Limited quarterly total operating expenses?
The current quarterly operating expenses of TEVA is $1.23B
What is the all time high quarterly operating expenses for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly total operating expenses is $2.39B
What is Teva Pharmaceutical Industries Limited quarterly operating expenses year-on-year change?
Over the past year, TEVA quarterly total operating expenses has changed by +$20.06M (+1.66%)